Results 11 to 20 of about 29,753 (220)

Thromboprophylaxis for trauma patients. [PDF]

Cochrane Database of Systematic Reviews, 2010
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of thromboprophylaxis in trauma patients on mortality and incidence of DVT and PE.
Acosta, Bauer, Cipolle, Cohn, Elliott, Evans, Fisher, Frezza, Geerts, Geerts, Geerts, Haentjens, Higgins, Hirsh, Hoffman, Kakkos, Knudson, Knudson, McMurtry, Meissner, Nijkeuter, O'Malley, Rogers, Rogers, Sauaia, Sevitt, Shackford, Smith, Spaniolas, Velmahos, Velmahos   +30 more
core   +9 more sources

Low-Molecular-Weight Heparin for Adult ICU Patients Who Require Thromboprophylaxis: Protocol for the INCEPT-Thromboprophylaxis Platform Trial Domain. [PDF]

Acta Anaesthesiol Scand
ABSTRACT Background Low‐molecular‐weight heparin (LMWH) is recommended for thromboprophylaxis in adult intensive care unit (ICU) patients. Despite its widespread use, there is insufficient evidence on the optimal dose, and there appears to be practice variation.
Eck R, Granholm A, Tøgern A, Jensen AKG, Jonmarker S, Sjövall F, Meijer K, Cronhjort M, Møller MH, Perner A, Keus F.   +10 more
europepmc   +2 more sources

Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C

Research and Practice in Thrombosis and Haemostasis, 2022
Background Limited data exist about effective regimens for pharmacological thromboprophylaxis in children with acute coronavirus disease 2019 (COVID‐19) and multisystem inflammatory syndrome in children (MIS‐C).
Anna H. Schmitz, Kelly E. Wood, Elliot L. Burghardt, Bryan P. Koestner, Linder H. Wendt, Aditya V. Badheka, Anjali A. Sharathkumar   +6 more
doaj   +1 more source

Safety and effectiveness of thromboprophylaxis use in hospitalized elderly medical patients at a Saudi tertiary care center

Saudi Pharmaceutical Journal, 2021
Introduction: Appropriate prescribing of thromboprophylaxis according to guidelines’ recommendations can heighten over- or underutilization risk. The study intended to evaluate the safety and effectiveness of appropriate/inappropriate thromboprophylaxis ...
Ghazwa B. Korayem, Omar A. Alshaya, Norah S. Alsubaie, Dalal A. Alabdulkarim, Omar A. Almohammed, Osamah M. Alfayez, Majed S. Al Yami   +6 more
doaj   +1 more source

Efficacy and safety of thromboprophylaxis in cancer patients: a systematic review and meta-analysis

Therapeutic Advances in Medical Oncology, 2020
Background: Thrombosis is a common complication in patients with cancer. Whether thromboprophylaxis could benefit patients with cancer is unclear.
Miao Liu, Guiyue Wang, Yuhang Li, Hongliang Wang, Haitao Liu, Nana Guo, Ci Han, Yahui Peng, Mengyuan Yang, Yansong Liu, Xiaohui Ma, Kaijiang Yu, Changsong Wang   +12 more
doaj   +1 more source

Thromboembolic complications during and after hospitalization for COVID-19: Incidence, risk factors and thromboprophylaxis

Thrombosis Update, 2022
Introduction: The incidence of thromboembolism during COVID-19 and the use of thromboprophylaxis vary greatly between studies. Only a few studies have investigated the rate of thromboembolism post-discharge.
Birgitte Tholin, Hilde Fiskvik, Anders Tveita, Galina Tsykonova, Helene Opperud, Kari Busterud, Clarisse Mpinganzima, Lamya Garabet, Jamal Ahmed, Knut Stavem, Waleed Ghanima   +10 more
doaj   +1 more source

Contemporary adequacy of thromboprophylaxis in acutely ill medical patients in Switzerland: a bi-centric prospective cohort

Swiss Medical Weekly, 2023
BACKGROUND: Venous thromboembolism is a dreaded complication of hospitalised patients, with associated morbidity, mortality and increased healthcare costs.
Marco Marando, Katherine Blondon, Pauline Darbellay Farhoumand, Mathieu Nendaz, Damien Grauser, Alain Sallet, Adriana Tamburello, Marco Pons, Marc Righini , Pietro Gianella, Marc Blondon   +10 more
doaj   +1 more source

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma. [PDF]

, 2018
It is common knowledge that cancer patients are more prone to develop venous thromboembolic complications (VTE). It is therefore not surprising that patients with hepatocellular carcinoma (HCC) present with a significant risk of VTE, with the portal vein
Burra, P, Campello, E, Russo, Fp., Simioni, P, Spiezia, L, Zanetto, A   +5 more
core   +1 more source

Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]

, 2006
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Altinbas M, Athanasoulis CA, Bergqvist D, Bergqvist D, Buller HR, Clagett PG, Da Silva MS, Decousus H, ENOXACAN Study Group, Falanga A, Geerts WH, Gitter MJ, Goldenberg N, Gomes MPV, Green D, Haas S, Heit JA, Hettiarachchi RJK, Hull R, Hutten BA, International Multicentre Trial, Johnson MJ, Kakkar VV, Karthaus M, Koopman MMW, Levine MN, Mousa S A, Mousa SA, Prandoni P, Rasmussen MS, Rickles FR, Sallah S, Samama M, Siragusa B, The Columbus Investigators, White RH, Zacharski LR   +36 more
core   +1 more source

Prescribing patterns of thromboprophylaxis post-bariatric surgeries: no additional benefits of extended prophylaxis

Future Journal of Pharmaceutical Sciences, 2023
Background Venous thromboembolism is one of the critical complications of bariatric surgeries resulting in life-threatening outcomes. The benefits and duration of appropriate thromboprophylaxis in the morbidly obese patients stay unclear.
Abdullah S. Almalki, Heba Adel Al Recheq, Eshtyage Bajnaid, Sherif Boraii, Doaa H. Abdelaziz, Seif El Hadidi   +5 more
doaj   +1 more source